AQUINOX PHARMACEUTICALS
Aquinox Pharmaceuticals Inc., a pharmaceutical company, engages in discovery, development, and commercialization of small molecule therapeutics for the treatment of cancer and inflammatory disease. It offers AQX-MN100, a drug used to treat cancer and inflammatory disease, as well as SH2-containing inositol 5'-phosphatase inhibition program for blood cell recovery. The company was founded in 2004 and is based in Vancouver, Canada.
AQUINOX PHARMACEUTICALS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.aqxpharma.com
Total Employee:
11+
Status:
Active
Contact:
604.629.9223
Email Addresses:
[email protected]
Total Funding:
221.39 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Google Maps LetsEncrypt SSL By Default IPv6
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-06 | Neoleukin Therapeutics | Neoleukin Therapeutics acquired by Aquinox Pharmaceuticals | 40 M USD |
Investors List
Cowen Group
Cowen Group investment in Post-IPO Equity - Aquinox Pharmaceuticals
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series C - Aquinox Pharmaceuticals
Inbio Ventures
Inbio Ventures investment in Series C - Aquinox Pharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - Aquinox Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series C - Aquinox Pharmaceuticals
Ventures West
Ventures West investment in Series C - Aquinox Pharmaceuticals
Augment Investments
Augment Investments investment in Series C - Aquinox Pharmaceuticals
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Aquinox Pharmaceuticals
Ventures West
Ventures West investment in Series B - Aquinox Pharmaceuticals
BC Advantage Funds
BC Advantage Funds investment in Series B - Aquinox Pharmaceuticals
Official Site Inspections
http://www.aqxpharma.com Semrush global rank: 9.11 M Semrush visits lastest month: 445
- Host name: 89.117.217.220
- IP address: 89.117.217.220
- Location: Širvintos Republic of Lithuania
- Latitude: 55.05
- Longitude: 24.95
- Timezone: Europe/Vilnius
- Postal: 19001
More informations about "Aquinox Pharmaceuticals"
Aquinox Pharmaceuticals - VentureRadar
"Aquinox Pharmaceuticals is the world leader in the discovery and development of novel, first-in-class, small molecule therapeutics targeting SH2-containing inositol-5’-phosphatase ("SHIP1") …See details»
Aquinox Pharmaceuticals, Inc. - SignalHire
Organization Website: aqxpharma.com : Social Links: Phone Number: 604-629-9223: Aquinox Pharmaceutic... industries Biotech: Headquarters Location: 887 Great Northern Way, …See details»
Aquinox Pharmaceuticals Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aquinox Pharmaceuticals Inc. of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Aquinox Canada - pharmaboardroom.com
Aquinox Pharmaceuticals, Inc. commenced operations in 2006 as a spin-off from the University of British Columbia, the BC Cancer Agency, and the Vancouver Coastal Health Research …See details»
Aquinox Pharmaceuticals (Canada) Inc. - The Canadian Grocer
Aquinox is developing novel, small molecule therapeutics targeting SH2-containing inositol-5′-phosphatase 1 (“SHIP1”) for the treatment of inflammatory disease and cancer.See details»
Aquinox Pharmaceuticals - Pharmstd Ventures
Www.aqxpharma.com. Aquinox Latest News 26.05.2013 Aquinox Awarded by Canadian Biotech Industry Organization 03.04.13 Aquinox investment Read more news. ← Previous. Neon …See details»
Aquinox Pharmaceuticals - Products, Competitors, Financials, …
Headquarters Location. Suite 450 – 887 Great Northern Way . Vancouver, British Columbia, V5T 4T5, Canada. 604-629-9223See details»
Aquinox Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore Aquinox Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 11 clinical trials, 10 news, and 1 literature, Disease Domain ...See details»
investor.aqxpharma.com
Investor.aqxpharma.comSee details»
10-K/A - SEC.gov
EXPLANATORY NOTE . Aquinox Pharmaceuticals, Inc. (the “Company”) is filing this Amendment No. 1 to its Annual Report on Form 10-K (“Amendment”), originally filed with the Securities and …See details»
AQXP - Aquinox Pharmaceuticals Company Profile - StockInvest.us
Aquinox Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics in disease areas of ...See details»
Aquinox Pharmaceuticals Completes $14.5 Million Series A
VANCOUVER, June 12 /PRNewswire/ - Aquinox Pharmaceuticals Inc., a Vancouver-based privately-held pharmaceutical company developing targeted small molecule therapeutics for …See details»
Aquinox Pharmaceuticals Announces Initiation of ProShip
Jun 11, 2018 Investors: Brendan Payne Associate Director, Investor Relations Aquinox Pharmaceuticals, Inc. 604.901.3019 [email protected]: Media: Lisa Guiterman OrangefierySee details»
Aquinox Announces Appointment of Dr. Kelvin Neu and Dr.
Mar 27, 2017 VANCOUVER, British Columbia, March 27, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical …See details»
Aquinox Pharmaceuticals | CipherBio
Explore Aquinox Pharmaceuticals's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
$AQXP Dr. #BarbaraTroupin as #CMO (Chief Medical Officer)
Oct 3, 2016 VANCOUVER, British Columbia, Oct. 03, 2016 — Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and …See details»
Meeting the Unique IP Management Needs of Pharmaceutical …
The AQX Pharma™ IP Management platform empowers pharmaceutical companies to focus on relationships between IP and drug products throughout the lifecycle of each. The platform …See details»
Aquinox Pharmaceuticals - VentureRadar
Website: http://www.aqxpharma.com. Similar Companies: Aquinox Pharmaceuticals is the world leader in the discovery and development of novel, first-in-class, small ...See details»
Anaqua Introduces AQX Pharma
Jan 17, 2023 With the introduction of AQX Pharma™, pharmaceutical companies now have the tools to maximize their market exclusivity, improve decision-making on product and IP …See details»
Quanterix and Akoya Biosciences Announce Amended Merger …
1 day ago Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination. BILLERICA, Mass. and MARLBOROUGH, Mass. – April 29, 2025 – Quanterix …See details»